115372 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5599)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115372)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reconciling the prospect of disease progression with goals and expectations: Development and validation of a measurement model in advanced cancer
    Journal Article

    George, L S.; Polacek, L. C.; Lynch, K.; Prigerson, H. G.; Abou-Alfa, G. K.; Atkinson, T. M.; Epstein, A. S.; Breitbart, W.
    Psycho-Oncology (2022)

    Fulltext@MSK | Save
  • Medical schools as gatekeepers: A survey and analysis of factors predicting dermatology residency placement
    Research Letter

    Ogidi, P.; Ahmed, F.; Cahn, B. A.; Chu, B.; Lipoff, J. B.
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save
  • Food and Drug Administration's proposed sunscreen final administrative order: How does it affect sunscreens in the United States?
    Correspondence

    Lim, H. W.; Mohammad, T. F.; Wang, S. Q.
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save
  • Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): A multicentre, randomised, phase 3 trial
    Journal Article

    Safran, H. P.; Winter, K.; Ilson, D. H.; Wigle, D; DiPetrillo, T; Haddock, M .; Hong, T. S.; Leichman, L. P.; Rajdev, L.; Resnick, M.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: An open-label, randomised, phase 3 trial
    Journal Article

    Cella, D.; Motzer, R. J.; Suarez, C.; Blum, S. I.; Ejzykowicz, F.; Hamilton, M.; Wallace, J. F.; Simsek, B.; Zhang, J.; Ivanescu, C.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • LI-RADS treatment response algorithm: Performance and diagnostic accuracy with radiologic-pathologic explant correlation in patients with SBRT-treated hepatocellular carcinoma
    Journal Article

    Mendiratta-Lala, M.; Aslam, A.; Maturen, K. E.; Westerhoff, M.; Maurino, C.; Parikh, N. D.; Sun, Y.; Sonnenday, C. J.; Stein, E. B.; Shampain, K. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Assessment of guideline-nonconcordant radiotherapy in Medicare beneficiaries with metastatic cancer near the end of life, 2015-2017
    Research Letter

    Santos, P. M. G.; Mathis, N. J.; Lapen, K.; Lobaugh, S.; Yerramilli, D.; Bekelman, J. E.; Gillespie, E. F.
    JAMA Health Forum (2022)

    Fulltext@MSK | Save
  • Should we contour cardiac substructures in routine practice? How autosegmentation helped get us there (or not)
    Editorial

    Gillespie, E. F.; Rodin, D.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Tepotinib in patients with advanced NSCLC with MET amplification (METamp)
    Meeting Abstract

    Le, X.; O'Hara, R.; Paz-Ares, L.; Van Meerbeeck, J. P.; Viteri Ramirez, S.; Cabrera Galvez, C.; Vincente Baz, D.; Kim, Y. C.; Kang, J. H.; Schumacher, K. M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • DREAM3R: DuRvalumab with chEmotherapy as first line treAtment in advanced pleural mesothelioma: A phase 3 randomised trial
    Meeting Abstract

    Forde, P.; Kindler, H.; Zauderer, M.; Sun, Z.; Ramalingam, S.; Anagnostou, V.; Brahmer, J. R.; Nowak, A. K.; Kok, P. S.; Brown, C.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save